Kymera Therapeutics, Inc. (KYMR)
107.39
-2.73
(-2.48%)
USD |
NASDAQ |
Oct 02, 16:00
107.48
+0.09
(+0.08%)
After-Hours: 20:00
Kymera Therapeutics Market Cap : 8.891B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 8.891B |
| October 01, 2026 | 9.117B |
| September 30, 2026 | 9.255B |
| September 29, 2026 | 9.149B |
| September 28, 2026 | 9.272B |
| September 25, 2026 | 9.268B |
| September 24, 2026 | 9.588B |
| September 23, 2026 | 9.560B |
| September 22, 2026 | 10.11B |
| September 21, 2026 | 9.742B |
| September 18, 2026 | 9.748B |
| September 17, 2026 | 9.809B |
| September 16, 2026 | 9.631B |
| September 15, 2026 | 9.367B |
| September 14, 2026 | 9.490B |
| September 11, 2026 | 9.517B |
| September 10, 2026 | 9.686B |
| September 09, 2026 | 9.556B |
| September 08, 2026 | 9.642B |
| September 04, 2026 | 9.719B |
| September 03, 2026 | 9.709B |
| September 02, 2026 | 9.821B |
| September 01, 2026 | 9.856B |
| August 31, 2026 | 9.836B |
| August 28, 2026 | 9.781B |
| Date | Value |
|---|---|
| August 27, 2026 | 9.954B |
| August 26, 2026 | 10.39B |
| August 25, 2026 | 10.48B |
| August 24, 2026 | 10.02B |
| August 21, 2026 | 9.918B |
| August 20, 2026 | 10.06B |
| August 19, 2026 | 10.54B |
| August 18, 2026 | 10.05B |
| August 17, 2026 | 10.05B |
| August 14, 2026 | 9.719B |
| August 13, 2026 | 9.473B |
| August 12, 2026 | 9.440B |
| August 11, 2026 | 9.075B |
| August 10, 2026 | 8.989B |
| August 07, 2026 | 8.901B |
| August 06, 2026 | 8.810B |
| August 05, 2026 | 8.733B |
| August 04, 2026 | 8.642B |
| August 03, 2026 | 8.304B |
| July 31, 2026 | 8.498B |
| July 30, 2026 | 8.794B |
| July 29, 2026 | 8.650B |
| July 28, 2026 | 8.724B |
| July 27, 2026 | 9.044B |
| July 24, 2026 | 9.087B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sangamo Therapeutics, Inc. | 61.11M |
| Sarepta Therapeutics, Inc. | 1.848B |
| Anixa Biosciences, Inc. | 102.02M |
Market Cap Related Metrics
| PS Ratio | 95.35 |
| Price to Book Value | 5.891 |
| Price | 107.39 |
| Earnings Yield | -3.02% |